Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
"This case reflects a troubling pattern in which payers, dissatisfied with IDR results, increasingly try to attack those outcomes outside the framework Congress created," Rad Partners says.
“Expanding residency slots and mitigating workforce attrition will be necessary to mitigate increasing workforce gaps," experts write in the Journal of the American College of Radiology.
According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products.
If the budget makes it through Congress intact as submitted—a big if even with the president’s party in the majority in both chambers—healthcare is in for some strict belt-tightening.
The system was cleared by the U.S. Food and Drug Administration in September and was adopted by the interventional team at Atlanta-based Emory shortly after.